FTIH of ECC4703 in Healthy Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a Phase 1, randomized, double-blind, placebo-controlled, single ascending dose and multiple ascending dose study of ECC4703 in healthy volunteers and participants with treatment unnecessary LDL-C under 160 mg/dL
Epistemonikos ID: c3166aa587acefd02b610ae7f9e80635aadf14aa
First added on: May 13, 2024